Ortho's Eprex (erythropoietin)
Executive Summary
Ortho's Eprex (erythropoietin): Preliminary results of trial for severe anemia associated with AZT therapy in AIDS patients shows "reduction in blood transfusion requirements," Ortho VP-Biotechnology and Development Seth Rudnick, MD, reported at the Oct. 12-American Association of Blood Banks meeting. Ortho licenses the recombinant human erythropoietin product from Amgen.